Looking to sell BioIntellisense stock or options?Contact us
BioIntellisense has developed a cutting-edge clinical intelligence platform for continuous health monitoring, predictive analytics, and advanced clinical insights. Their platform is designed to offer medical-grade monitoring services by utilizing a sensor-enabled wearable device that is placed on the skin. The device performs state-of-the-art analytics and data services for early detection of skin temperature, heart rate, respiratory rate, fall detection, and frequency of coughing, sneezing, and vomiting. This real-time data is relayed to the platform, allowing hospitals to evaluate vital signs, physiological biometrics, and symptomatic events of patients.
Chimera Capital, Dexcom Ventures, Mary Tolan, University of Colorado Health, Pendrell, Philips, iD Ventures America, TT Capital Partners, Fresenius Medical Care, Royal Philips Electronics (Restoratives and Impression Portfolios), CU Healthcare Innovation Fund, Philips Ventures, Skypoint Ventures, United States Army, James Murren, TLG Capital Management, Jonathan Weiner.
We have an even better solution: The Collective Exchange Fund
Get in touch and see if we can help you